Karin Eastham Veracyte, Inc. (VCYT) insider trading activity

VCYT Quotes by TradingView

Karin Eastham is Director of VERACYTE, INC.. Currently has a direct ownership of 23,228 shares of VCYT, which is worth approximately $562,582. The most recent transaction as insider was on Jun 18, 2025, when has been sold 9,321 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 23.2K
25.58% 3M change
30.1% 12M change
Total Value Held $562,582

KARIN EASTHAM Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 18 2025
BUY
Grant, award, or other acquisition
-
9,321 Added 28.64%
23,228 Common Stock
Jun 13 2025
SELL
Open market or private sale
$122,369 $26.66 p/Share
4,590 Reduced 24.81%
13,907 Common Stock
Jan 02 2025
SELL
Open market or private sale
$403,100 $40.31 p/Share
10,000 Reduced 35.09%
18,497 Common Stock
Jan 02 2025
BUY
Exercise of conversion of derivative security
$52,800 $5.28 p/Share
10,000 Added 25.98%
28,497 Common Stock
Nov 19 2024
SELL
Open market or private sale
$556,389 $37.77 p/Share
14,731 Reduced 44.33%
18,497 Common Stock
Jul 16 2024
SELL
Open market or private sale
$187,500 $25.0 p/Share
7,500 Reduced 18.41%
33,228 Common Stock
Jun 13 2024
BUY
Grant, award, or other acquisition
-
11,473 Added 21.98%
40,728 Common Stock
Jun 11 2024
SELL
Open market or private sale
$79,683 $20.59 p/Share
3,870 Reduced 11.68%
29,255 Common Stock
Jun 07 2024
SELL
Open market or private sale
$52,425 $20.97 p/Share
2,500 Reduced 7.02%
33,125 Common Stock
Jun 07 2024
BUY
Exercise of conversion of derivative security
$26,025 $10.41 p/Share
2,500 Added 6.56%
35,625 Common Stock
Apr 01 2024
SELL
Open market or private sale
$216,500 $21.65 p/Share
10,000 Reduced 23.19%
33,125 Common Stock
Apr 01 2024
BUY
Exercise of conversion of derivative security
$131,900 $13.19 p/Share
10,000 Added 18.82%
43,125 Common Stock
Jun 09 2023
BUY
Grant, award, or other acquisition
-
9,674 Added 22.6%
33,125 Common Stock
Mar 16 2023
SELL
Open market or private sale
$427,125 $22.78 p/Share
18,750 Reduced 44.43%
23,451 Common Stock
Mar 16 2023
BUY
Exercise of conversion of derivative security
$227,249 $12.12 p/Share
18,750 Added 30.76%
42,201 Common Stock
Feb 28 2023
SELL
Open market or private sale
$250,000 $25.0 p/Share
10,000 Reduced 29.89%
23,451 Common Stock
Feb 28 2023
BUY
Exercise of conversion of derivative security
$121,199 $12.12 p/Share
10,000 Added 23.01%
33,451 Common Stock
Jun 16 2022
BUY
Grant, award, or other acquisition
-
14,731 Added 38.58%
23,451 Common Stock
Dec 17 2021
SELL
Open market or private sale
$225,000 $45.0 p/Share
5,000 Reduced 36.44%
8,720 Common Stock
Dec 17 2021
BUY
Exercise of conversion of derivative security
$60,600 $12.12 p/Share
5,000 Added 26.71%
13,720 Common Stock
Jun 08 2021
BUY
Grant, award, or other acquisition
-
8,720 Added 50.0%
8,720 Common Stock
Feb 25 2021
SELL
Open market or private sale
$381,000 $60.96 p/Share
6,250 Reduced 100.0%
0 Common Stock
Feb 25 2021
BUY
Exercise of conversion of derivative security
$25,000 $4.0 p/Share
6,250 Added 50.0%
6,250 Common Stock

Also insider at

GERN
GERON CORP Healthcare
Director
PSNL
Personalis, Inc. Healthcare
NKTR
NEKTAR THERAPEUTICS Healthcare
Director
KE

Karin Eastham

Director
San Francisco, CA

Track Institutional and Insider Activities on VCYT

Follow VERACYTE, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells VCYT shares.

Notify only if

Insider Trading

Get notified when an Veracyte, Inc. insider buys or sells VCYT shares.

Notify only if

News

Receive news related to VERACYTE, INC.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on VCYT